Zydus MedTech has partnered with Brazil-based Braile Biomedica to commercialize innovative TAVI technology across Europe, ...

A U.S. District Court recently ruled against Zydus and Lupin, finding Astellas's patent for Myrbetriq was not invalid. Both ...

The litigation was initiated by Astellas Pharma against Zydus Lifesciences concerning the validity of the ‘780 patent’, which ...

Astellas Pharma Inc. defeated two generic-drug makers’ key invalidity defenses over a patent for Myrbetriq ER in a long-running clash over copycat versions of the overactive-bladder treatment. The ...

Easy Trip Planners Ltd, Dhani Services Ltd, Mahanagar Gas Ltd and Astrazeneca Pharma India Ltd are among the other losers in the BSE's 'A' group today, 16 April 2025.

Lupin Ltd. and Zydus Lifesciences Ltd. shares fell sharply after a US court upheld Astellas Pharma's patent on Myrbetriq, ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

The GIFT Nifty was indicating a muted start for Indian benchmarks on Tuesday. ICICI Bank Ltd., HCLTech Ltd., and Zydus Lifesciences Ltd. share prices are expected to move because of the news flow over ...

Explore the latest stock alerts: Macrotech, Reliance, Vedanta, Dr Reddy's, and more. Check out key developments today!

Among top donors to major parties, at least five companies are facing probes by central agencies, of which four have donated ...